Please try another search
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; urea breath test kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment sells medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications; and sells radiation therapy equipment and other miscellaneous services. In addition, the company engages in the production and sale of bio-pharmaceuticals. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
Name | Age | Since | Title |
---|---|---|---|
Guoping Zhang | 51 | 2019 | Supervisor |
Zhonglin Liu | 54 | 2021 | Chairman of the Board of Supervisors |
Jingshan Chen | 53 | 2021 | Independent Non-Executive Director |
Qihui Peng | 30 | 2022 | Employee Representative Supervisor |
Fuxin Ma | 32 | 2022 | Employee Representative Supervisor |
Chuang Lu | 44 | 2021 | Independent Non-Executive Director |
Nanfei Zhao | 43 | 2021 | Supervisor |
Jinyu Chang | 52 | 2019 | Non Executive Director |
Jiahe Tian | 73 | 2019 | Independent Non-Executive Director |
Jianmin Ding | 51 | 2023 | Non-Executive Director |
Chiu Kwok Poon | 62 | 2023 | Independent Non-Executive Director |
Xiuhong Liu | 57 | 2020 | Non-Executive Director |
Junqi Zhang | 52 | 2023 | Executive Chairman |
Guomin Fan | 53 | 2023 | Deputy GM & Executive Director |
Yao Wang | - | 2024 | Executive Director |
Shoulei Chen | 58 | 2017 | Vice Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review